We are live on ! Find out more
CJ

Caitlin John Portfolio holdings

AUM $183M Turnover 19.83%
1-Year Est. Return 30.77%
This Fund
S&P 500
This Quarter Est. Return
+15.34%
1 Year Est. Return
+30.77%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$183M
AUM Growth
+$16.5M
Cap. Flow
+$7.27M
Cap. Flow %
3.97%
Top 10 Hldgs %
21.01%
Holding
1,074
New
140
Increased
236
Reduced
229
Closed
73
Avg Time Held Equity + Options
0.8 years
Top 10 Avg Time Held Equity + Options
0.5 years
Top 20 Avg Time Held Equity + Options
0.6 years
Avg Time Held Equity only
0.8 years
Top 10 Avg Time Held Equity only
0.5 years
Top 20 Avg Time Held Equity only
0.6 years
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
EMTY icon
926
ProShares Decline of the Retail Store ETF
EMTY
$2.88M
$598 ﹤0.01%
25
– –
2025 Q3
3 quarters
LAD icon
927
Lithia Motors
LAD
$6.58B
$580 ﹤0.01%
2
-1,222
-100% -$347K
2025 Q4
2 quarters
RELX icon
928
RELX
RELX
$68.4B
$570 ﹤0.01%
18
– –
2025 Q3
3 quarters
TROW icon
929
T. Rowe Price
TROW
$21.8B
$554 ﹤0.01%
5
-5
-50% -$511
2025 Q3
3 quarters
GTLB icon
930
GitLab
GTLB
$9.16B
$550 ﹤0.01%
18
– –
2026 Q1
1 quarter
HUBS icon
931
HubSpot
HUBS
$12.5B
$548 ﹤0.01%
+3
New +$627
2026 Q2
0 quarters
LUMN icon
932
Lumen Technologies, Inc. Common Stock
LUMN
$4.62B
$545 ﹤0.01%
71
– –
2025 Q3
3 quarters
TEAM icon
933
Atlassian
TEAM
$56B
$545 ﹤0.01%
7
+5
+250% +$409
2025 Q4
2 quarters
MDGL icon
934
Madrigal Pharmaceuticals
MDGL
$10.8B
$537 ﹤0.01%
1
-1
-50% -$512
2025 Q3
3 quarters
ACH icon
935
Accendra Health
ACH
$19.6M
$534 ﹤0.01%
156
– –
2025 Q3
3 quarters
IT icon
936
Gartner
IT
$13.9B
$518 ﹤0.01%
4
– –
2025 Q3
3 quarters
APP icon
937
Applovin
APP
$91.2B
$515 ﹤0.01%
1
– –
2026 Q1
1 quarter
VRNS icon
938
Varonis Systems
VRNS
$5.59B
$504 ﹤0.01%
12
– –
2025 Q4
2 quarters
TMO icon
939
Thermo Fisher Scientific
TMO
$254B
$501 ﹤0.01%
+1
New +$480
2026 Q2
0 quarters
ASTI icon
940
Ascent Solar Technologies
ASTI
$17.7M
$500 ﹤0.01%
100
– –
2026 Q1
1 quarter
CIFR icon
941
Cipher Digital
CIFR
$3.69B
$490 ﹤0.01%
20
– –
2026 Q1
1 quarter
MED icon
942
Medifast
MED
$135M
$488 ﹤0.01%
46
– –
2025 Q3
3 quarters
SAP icon
943
SAP
SAP
$264B
$487 ﹤0.01%
3
– –
2025 Q3
3 quarters
GRFS icon
944
Grifois
GRFS
$5.13B
$467 ﹤0.01%
66
– –
2025 Q3
3 quarters
SOLV icon
945
Solventum
SOLV
$14.7B
$463 ﹤0.01%
6
– –
2025 Q3
3 quarters
FSLY icon
946
Fastly Inc
FSLY
$3.52B
$459 ﹤0.01%
+25
New +$543
2026 Q2
0 quarters
SPOT icon
947
Spotify
SPOT
$108B
$459 ﹤0.01%
1
– –
2025 Q3
3 quarters
IREN icon
948
Iris Energy
IREN
$10.5B
$457 ﹤0.01%
10
– –
2026 Q1
1 quarter
FRT icon
949
Federal Realty Investment Trust
FRT
$9.26B
$448 ﹤0.01%
4
– –
2025 Q3
3 quarters
BA icon
950
Boeing
BA
$151B
$433 ﹤0.01%
2
– –
2025 Q3
3 quarters

Similar funds

Caitlin John's Q2 2026 Portfolio in Review

As of Q2 2026, Caitlin John held 1,074 positions worth $183M, up 9.9% from $167M the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Caitlin John deployed $7.27M of net new capital in Q2 2026, opening 140 new positions and adding to 236 existing holdings. Its largest new stake was Janus Henderson AAA CLO ETF: 47,387 shares worth $2.39M.

By sector, the portfolio is most concentrated in Miscellaneous at 52% of assets, down from 67% a quarter earlier, followed by Technology and Financials.

On the sell side, the largest reduction was State Street SPDR Bloomberg 1-3 Month T-Bill ETF, an estimated $10.9M trimmed.

  • Caitlin John's largest Q2 2026 buy was Janus Henderson AAA CLO ETF: 47,387 shares worth $2.39M.
  • Caitlin John added most to Invesco QQQ Trust in Q2 2026, an estimated $1.98M increase.
  • Caitlin John's biggest Q2 2026 reduction was State Street SPDR Bloomberg 1-3 Month T-Bill ETF, cutting an estimated $10.9M.
  • Caitlin John fully exited Leidos in Q2 2026, selling an estimated $156K.
  • Caitlin John's ten largest holdings make up 21% of its $183M portfolio in Q2 2026.
  • Caitlin John opened 140 new positions and closed 73 in Q2 2026.
  • Caitlin John's portfolio value rose 9.9% quarter-over-quarter to $183M.

Based on Caitlin John's 13F filing for Q2 2026, filed 17 Aug 2026.